# NUTRIMOOD-Inflammation and Depressive Comorbidity in Obesity: Modulation by Omega-3 Polyunsaturated Fatty Acids Status

> **NCT07439744** · NA · RECRUITING · sponsor: **National Science and Technology Council, Taiwan** · enrollment: 50 (estimated)

## Conditions studied

- Obese Adults
- MDD

## Interventions

- **DIETARY_SUPPLEMENT:** Eicosapentaenoic acid (omega-3 fatty acid)
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT07439744
- **Lead sponsor:** National Science and Technology Council, Taiwan
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2027-03
- **Final completion:** 2027-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07439744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07439744, "NUTRIMOOD-Inflammation and Depressive Comorbidity in Obesity: Modulation by Omega-3 Polyunsaturated Fatty Acids Status". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07439744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*